COGT Cogent Biosciences Inc

Price (delayed)

$32.81

Market cap

$5.61B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.17

Enterprise value

$5.6B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 4

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, PLX9486, is a selective tyrosine kinase inhibitor that is designed ...

Highlights
Cogent Biosciences's quick ratio has increased by 6% from the previous quarter
The company's equity has surged by 177% YoY but it fell by 4.5% QoQ
The company's net income fell by 31% YoY and by 8% QoQ
The EPS fell by 10% YoY

Key stats

What are the main financial stats of COGT

COGT stock price

How has the Cogent Biosciences stock price performed over time
Intraday
1.7%
1 week
-7.26%
1 month
-10.67%
1 year
481.74%
YTD
-7.63%
QTD
-14.76%

Financial performance

How have Cogent Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$362.04M
Net income
-$354.3M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 31% YoY and by 8% QoQ
COGT's operating income is down by 26% year-on-year and by 9% since the previous quarter

Price vs fundamentals

How does COGT's price correlate with its fundamentals

Growth

What is Cogent Biosciences's growth rate over time

Valuation

What is Cogent Biosciences stock price valuation
P/E
N/A
P/B
8.76
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS fell by 10% YoY
The company's equity has surged by 177% YoY but it fell by 4.5% QoQ
The P/B is 146% above the 5-year quarterly average of 3.5 and 15% above the last 4 quarters average of 7.5

Efficiency

How efficient is Cogent Biosciences business performance
COGT's return on invested capital is up by 45% year-on-year and by 29% since the previous quarter
The ROA has grown by 26% YoY and by 19% from the previous quarter
The company's return on equity rose by 17% QoQ and by 10% YoY

Dividends

What is COGT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for COGT.

Financial health

How did Cogent Biosciences financials performed over time
COGT's current ratio has surged by 195% year-on-year and by 6% since the previous quarter
Cogent Biosciences's quick ratio has increased by 6% from the previous quarter
The company's debt is 61% lower than its equity
The company's equity has surged by 177% YoY but it fell by 4.5% QoQ
Cogent Biosciences's debt to equity has increased by 2.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.